Longevity Breakfast

This curated breakfast brings investors face-to-face with two leaders shaping the future of longevity: Dr. Elisabeth Roider, physician-scientist and Chief Scientific & Medical Officer at Maximon, and Stefan Röhig, operator-turned-investor at R3 Capital.

Dr. Elisabeth Roider is a Harvard- and Swiss-trained physician-scientist, Chief Scientific & Medical Officer at Maximon, and one of Europe’s most influential voices in translating longevity research into real-world ventures. She leads cross-disciplinary teams from clinicians to machine-learning experts, ensuring that only the most scientifically credible and commercially viable ideas make it to market.

Stefan Röhig is the principal investor at 9 Ventures, backing ambitious founders in longevity and healthspan. A Harvard MBA and former founder/operator, he scaled consumer businesses globally before turning his focus to identifying and supporting the next generation of longevity companies. He is also an investor at R3 Capital and serves as a board member at the Bamed MAM Group, bringing over a decade of international operating experience to his investments.

Together they’ll cut through the noise and outline where longevity is truly investable today, what lies ahead, and how each of us can take steps now to extend our own healthspan.

What to Expect

• Clarity – Learn what to actually look for in longevity and preventive health when evaluating opportunities.

• Foresight – Hear where the field is heading in the coming years, from science to scalable business models.

• Personal Takeaways – Discover what you can do now—practical, evidence-based habits and practices to improve your own longevity.

This is a rare opportunity to hear two of the sharpest minds in longevity share their frameworks, filters, and foresight in a candid, closed-door setting. Expect perspectives you won’t find on stage—or anywhere else.